CURRENT STATUS AND ACHIEVEMENTS OF EXTRACORPOREAL HEMOCORRECTION IN KAZAKHSTAN: RECENT ACHIEVEMENTS AND CURRENT CHALLENGES
Topicality. This article represents information about the spread of extracorporeal hemocorrection methods, as well as the process of organization and introduction of modern extracorporeal hemocorrection technologies into the healthcare system of the Republic of Kazakhstan. Currently, in Astana, Kazakhstan, there is a Laboratory of Extracorporeal Hemocorrection on the basis of Corporate fund “University Medical Center” “Heart Center”.
Aim. To assess the current state of extracorporeal hemocorrection in Kazakhstan, to analyse the frequency of application of various methods, to identify key achievements and existing problems, and to propose possible solutions
Materials and methods of research. An analysis of extracorporeal hemocorrection techniques performed on patients who underwent cardiac surgery from 2017 to 2023 was conducted at the Corporate Fund "University Medical Center" Heart Center. Cases of plasmapheresis, hemosorption, and other extracorporeal therapy methods were identified.
Results and conclusion. Based on the presented analysis of the current state of the service of extracorporeal hemocorrection service in Kazakhstan, the cases and detailed analysis of the implementation of modern technologies and methods of extracorporeal therapy in the Corporate Fund University Medical Center “Heart Center” (Astana, Kazakhstan) are described. Attention is also focused on the shortcomings, significant gaps in the equipment of specialised centers and limited availability of these methods in regional medical institutions. In conclusion, recommendations are offered to improve the material and technical base, improve the qualifications of medical workers, and develop and implement national clinical protocols based on international standards.
Amanzholova Ainamkoz Kutzhanovna - PhD in Medicine, NpJSC «Astana Medical University», Astana, Kazakhstan.
Address: Astana, Kazakhstan, 010000, Turan street 38.
E-mail: aainamkoz7@gmail.com
Phone: +7 707 426 53 24
1. World Health Organisation. World health statistics 2019: monitoring health for the SDGs, sustainable development goals. Available at: https://www.who.int/publications-detail-redi rect/9789241565707
2. World Health Organisation. WHO reveals leading causes of death and disability worldwide: 2000-2019. Available at: https://www.who.int/news/item/09-12-2020-who-reveals-leading-causes-of death-and-disability-worldwide-2000-2019
3. Virani S.S., Alonso A., Aparicio H.J., Benjamin E.J., Bittencourt M.S., Cal laway C.W. et al. Heart Disease and Stroke Statistics – 2021 Update: A Report From the American Heart Association. Circulation. 2021. 143(8):e254–743. DOI: 10.1161/CIR.0000000000000950
4. Zhakhina G., Mussina K., Yerdessov S., Gusmanov A., Sakko Y., Kim V., Gaipov A. Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030. Renal Failure, 2024.46(1). https://doi.org/10.1080/0886022X.2024.2326312
5. Suhaii A. Manual of Clinical Dialysis, 2th ed. - 2011. - 304 с; 15,5 см. ISBN 978-5-98657-024-2.
6. Ronco C, Bellomo R. History and Development of Sorbents and Requirements for Sorbent Materials. Contrib Nephrol. 2023;200:2-7. doi: 10.1159/000529569. Epub 2023 Jun 1. PMID: 37263192
Количество просмотров: 38
Категория статей:
Оригинальное исследование
Библиографическая ссылка
Amanzholova A.K., Morenko M.A., Besbayeva G.K., Shnaider K.V., Koichubayeva D.K., Kurmangali A.U., Bekishev B.E. Current status and achievements of extracorporeal hemocorrection in Kazakhstan: recent achievements and current challenges // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (2), pp. 53-61. doi 10.34689/SH.2025.27.2.007Похожие публикации:
VIRAL HEPATITIS IN KAZAKHSTAN: REGIONAL EPIDEMIOLOGICAL OVERVIEW
PREDICTORS OF ANTIVIRAL THERAPY INEFFECTIVENESS IN CHRONIC HEPATITIS C: A MATCHED CASE-CONTROL STUDY IN ALMATY, A MAJOR METROPOLIS OF KAZAKHSTAN
МЕДИКО – СОЦИАЛЬНЫЕ ОСОБЕННОСТИ ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ БОЛЬНЫХ С ХРОНИЧЕСКИМ ПАНКРЕАТИТОМ
PATHOGENETIC ASSESSMENT OF CLINICAL AND INSTRUMENTAL PARAMETERS OF THE LUNGS IN PATIENTS WITH DIABETES MELLITUS
THE FREQUENCY AND EFFICACY ASSESSMENT OF RADIOIODINE THERAPY FOR DISTANT METASTASES OF THYROID CANCER